Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-015458
Filing Date
2025-06-17
Accepted
2025-06-17 17:19:13
Documents
1
Period of Report
2025-06-13

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3096
  Complete submission text file 0001641172-25-015458.txt   4585
Mailing Address 750 ROYAL OAKS DR MONROVIA CA 91016
Business Address 750 ROYAL OAKS DR MONROVIA CA 91016 (626) - 415 - 1488
EXOZYMES INC. (Issuer) CIK: 0002010788 (see all company filings)

EIN.: 834550057 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 428 HAWTHORNE AVE APT 218 GLENDALE CA 91204
Business Address
Opgenorth Paul Hideo (Reporting) CIK: 0002033517 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42204 | Film No.: 251054317